Loading chat...
FL S0168
Bill
AI Summary
- Hospitals providing neonatal intensive care must screen newborns for congenital cytomegalovirus (CMV) if admitted due to premature birth before 35 weeks' gestation, cardiac care, or medical/surgical treatment requiring an anticipated stay of 3 weeks or longer, with screening initiated before the newborn reaches 21 days of age
- Newborns who fail a hearing screening at any hospital or state-licensed birthing facility must be tested for congenital CMV before 21 days of age or before discharge, whichever occurs earlier
- When a newborn is transferred to another hospital for a higher level of care, the receiving hospital must initiate CMV screening if it was not already performed by the transferring facility, regardless of hearing screening results for those in intensive and prolonged care
- CMV screening and any medically necessary follow-up reevaluations are covered benefits under the Medicaid fee-for-service program, with Medicaid HMO patients reimbursed directly at the Medicaid rate
- Children diagnosed with congenital CMV infection must be referred to a primary care physician for medical management; those diagnosed without hearing loss must be referred to the Children's Medical Services Early Intervention Program and deemed eligible for baseline evaluation and follow-up monitoring
- Effective date is July 1, 2024
Legislative Description
Congenital Cytomegalovirus Screenings
Last Action
Chapter No. 2024-164
5/13/2024
Committee Referrals
Fiscal Policy2/8/2024
Appropriations Subcommittee on Health and Human Services1/25/2024
Full Bill Text
No bill text available